Where your DNA places you among other people, and the studies behind it.
Not tailored to your result, and not medical advice
Control Your Other Heart Risks: Lp(a) concentration itself barely responds to behavior, so the leverage sits in the other drivers of arterial disease. One arm of a factorial Mendelian randomization study of 385,917 UK Biobank participants paired genetically lower Lp(a) with five modifiable exposures, and each combination was associated with lower cardiovascular risk: lower systolic blood pressure (HR 0.81), less smoking (0.85), lower body mass index (0.87), more leisure-time physical activity (0.90) and less alcohol (0.90). The authors found no statistical interaction between the two arms, meaning the behavioral benefit appeared to add to the Lp(a) effect rather than depend on it. International Journal of Epidemiology (PMC)
Do Not Expect Diet to Lower It: This is the trait where the honest answer is that diet does not fix the problem. In controlled feeding trials, replacing saturated fat lowered LDL cholesterol consistently but moved Lp(a) unpredictably and often upward: in DELTA 1, swapping saturated fat for carbohydrate raised Lp(a) by about 15 percent, and in DELTA 2 the same swap raised it by 20 percent while a swap to monounsaturated fat raised it by 11 percent. A 2020 review of that literature concluded there is insufficient evidence to make dietary recommendations for people with high Lp(a), and that no diet-induced change in Lp(a) has been shown to change cardiovascular events. Eating well remains worthwhile for the heart in general, but it is not a reliable lever on this particular particle. Nutrients (PMC)
Ask About an Lp(a) Test: Lp(a) is not measured in most people, and it is reported on its own rather than derived from the usual cholesterol numbers, so a normal-looking lipid result says nothing about it. The American Heart Association describes levels as roughly 70 to more than 90 percent genetically determined, and notes that in the absence of other clinical conditions they have not been shown to change substantially across the life course, so they do not drift much with weight or diet. The same statement notes that Black individuals of African descent and South Asian populations have higher median Lp(a) than White or East Asian individuals. Whether measuring it makes sense is a reasonable thing to raise with a clinician. American Heart Association (PMC)
Take New Breathlessness Seriously: Lp(a) carries most of the oxidized phospholipids that circulate bound to lipoproteins, more than 85 percent of that pool, and those lipids are thought to activate inflammatory signalling in valve cells and push them toward a bone-forming state. That mechanism links Lp(a) to calcific aortic valve stenosis as well as to coronary disease. In the Copenhagen studies a ten-fold higher Lp(a) carried an observational hazard ratio of 1.4 for aortic stenosis, and Mendelian randomization produced a comparable causal estimate of 1.38 per standard deviation. Aortic stenosis is silent for years, so new breathlessness on exertion, chest tightness or fainting are worth getting looked at rather than explained away. Current Opinion in Cardiology (PMC)
Treat It as Family Information: Lp(a) is unusual among cardiovascular risk markers in being set predominantly at a single locus. The European Atherosclerosis Society consensus statement puts more than 90 percent of the variation between people down to genetic variability at LPA, with the Kringle-IV repeat polymorphism alone explaining an estimated 30 to 70 percent of it. Because the pattern is inherited that directly, close blood relatives often fall in a similar range, so what one family member learns about their own level is often relevant to siblings, parents and children. Passing that information along is entirely within your control, and what any of them does with it belongs with their own clinician. European Atherosclerosis Society, European Heart Journal (PMC)
How much of this is genetic?
Genetics explains 80% of why people differ in this trait. The rest is environment, daily habits and chance.
Heritability estimate: Kronenberg F, Utermann G. Lipoprotein(a): resurrected by genetics. J Intern Med, 2013
Background and further reading
Lipoprotein(a), often written Lp(a), is a low-density-lipoprotein-like particle in which an extra protein called apolipoprotein(a) is attached to the LDL particle. Blood levels vary more than a thousand-fold between people, and unlike ordinary LDL cholesterol, an individual's Lp(a) level is set largely at birth and stays remarkably stable throughout life. Elevated Lp(a) is common: roughly one in five people worldwide carry levels in the range that population studies associate with greater atherosclerotic cardiovascular disease and calcific aortic valve stenosis. Because it is not routinely measured, many people with high levels are unaware of it.
Genetic Basis: Lp(a) is among the most heritable of all common biomarkers, with twin and family studies attributing roughly 70 to 90 percent of the variation in blood levels to genetics. The overwhelming majority of that inheritance traces to a single gene, LPA, which encodes apolipoprotein(a). A variable stretch of DNA in LPA called the kringle IV type-2 (KIV-2) repeat differs in copy number between people; fewer repeats generally produce a smaller apo(a) isoform and higher Lp(a) levels, while more repeats tend to produce lower levels. Additional single-nucleotide variants at the LPA locus fine-tune levels further. Because so much of the signal sits at one locus with strong effects, a polygenic score for Lp(a) captures an unusually large share of the trait compared with most biomarkers.
Environmental Factors: Lp(a) stands apart from other lipid measures in how little lifestyle changes it. Diet, exercise, and standard statin therapy have minimal effect on Lp(a) levels, and statins may even nudge it modestly upward. Levels are broadly stable across adulthood, though they can rise somewhat after menopause and with kidney impairment, and they differ on average between ancestry groups. Because Lp(a) is so genetically fixed, it is often thought of as a lifelong, largely non-modifiable characteristic rather than something shaped day to day by habits. Where Lp(a) is elevated, general cardiovascular health measures address overall risk even though they do not lower the particle itself.
The published research behind your score, and the variants it draws on.
10 published scores from 5 studies
The lipoprotein(a) score combines 10 polygenic scores drawn from 5 published studies.
These traits are influenced by some of the same genes and variants as this one
Content updated August 2026.
ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.
Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026
Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com